References:
1.Medicines for Europe: Biosimilar Medicines clinical use Available at: http://bit.ly/2j0EJGt. Accessed March 2018. 2.The benefits of biosimilar medicines. Available at: https://bit.ly/2DsdBvR. Accessed April 2018. 3.United Nations. World Aging Report. Available at: http://bit.ly/1Y2LeF4. Accessed March 2018. 4.Healthy Aging at a Glance 2011. Available at: http://bit.ly/2ptzYJS. Accessed March 2018. 5.QuintilesIMS Institute for Healthcare Informatics. Global Medicines Use in 2020: Outlook and Implications. 2015. Available at: http://bit.ly/1H9Nze3. Accessed March 2018. 6.QuintilesIMS Institute for Healthcare Informatics. Delivering on the Potential of Biosimilar Medicines. Report. 2016. Available at: http://bit.ly/2D2HuPe. Accessed March 2018. 7.Orlewska L, et al. Med Sci Monit. 2011;17:SR1-13. 8.Li E, et al. Drug Des Devel Ther 2015;9:3247–55. 9.What you need to know about biosimilar medicinal products. Available at: http://bit.ly/29AZtNM. Accessed March 2018. 10.Biosimilar Medicines Group. Biosimilar Medicines Group handbook 2016. Available at: http://bit.ly/2q3qx0w. Accessed March 2018. 11.Simon-Kucher & Partners. Payers’ price & market access policies supporting a sustainable biosimilar medicines market. Available at: http://bit.ly/2q3qx0w Accessed March 2018. 12.Cornes P, Muenzberg M. Pharma Horizon 2016;1:35–38.